Search research articles
Contact Us
Filters
Showing results (421-430 of 516) with videos related to
Page
of 52
Sort By:
Stem Cell Research & Therapy
|
February 14, 2019
Correction to: Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization
Roni A Hazim, Saravanan Karumbayaram, Mei Jiang, et al.
Human Gene Therapy
|
September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency
Divya Punwani, Misako Kawahara, Jason Yu, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
December 2, 2008
[Lyme borreliosis: research gaps and research approaches. Results from an interdisciplinary expert meeting at the Robert Koch Institute]
G Poggensee, V Fingerle, K-P Hunfeld, et al.
Science Translational Medicine
|
October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 20, 2019
Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements
Richard A Morgan, Mildred J Unti, Bamidele Aleshe, et al.
Cell Stem Cell
|
February 16, 2016
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
Courtney S Young, Michael R Hicks, Natalia V Ermolova, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2008
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model
Arvind Chhabra, Lili Yang, Pin Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Cell Reports. Medicine
|
September 18, 2025
Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells
Eva E R Segura, Kevyn Hart, Beatriz Campo Fernandez, et al.
Blood Advances
|
April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease
Chattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Page
of 52
Search research articles
Search
Showing results (421-430 of 516) with videos related to
Sort By:
Page
of 52
Stem Cell Research & Therapy
|
February 14, 2019
Correction to: Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization
Roni A Hazim, Saravanan Karumbayaram, Mei Jiang, et al.
Human Gene Therapy
|
September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency
Divya Punwani, Misako Kawahara, Jason Yu, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
December 2, 2008
[Lyme borreliosis: research gaps and research approaches. Results from an interdisciplinary expert meeting at the Robert Koch Institute]
G Poggensee, V Fingerle, K-P Hunfeld, et al.
Science Translational Medicine
|
October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 20, 2019
Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements
Richard A Morgan, Mildred J Unti, Bamidele Aleshe, et al.
Cell Stem Cell
|
February 16, 2016
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
Courtney S Young, Michael R Hicks, Natalia V Ermolova, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2008
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model
Arvind Chhabra, Lili Yang, Pin Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Cell Reports. Medicine
|
September 18, 2025
Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells
Eva E R Segura, Kevyn Hart, Beatriz Campo Fernandez, et al.
Blood Advances
|
April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease
Chattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Page
of 52